Abstract
Using a non-myeloablative, immunosuppressive, fludarabine-based conditioning regimen, we performed allogeneic peripheral blood stem cell transplants totally on an outpatient basis in four patients (two with chronic myelogenous leukemia, one with acute myelogenous leukemia and one with thalassemia major). The median granulocyte recovery time to 0.5 × 109/l was 10 days and the lowest absolute neutrophil count was 0.064 × 109/l; only one patient developed thrombocytopenia below 20 × 109/l. No patient required red blood cell transfusions and one was given a single prophylactic platelet transfusion. All patients are alive at 210–390 (median 285) days and have definite evidence of chimerism; one developed biopsy-proven GVHD on day 50, with a limited cutaneous rash. The procedure is less costly than its counterpart using myeloablative conditioning regimens and may represent another approach in the management of patients requiring an allogeneic stem cell transplant. Bone Marrow Transplantation (2000) 25, 131–133.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Negrin R, Storb R, Forman S . Bone marrow transplantation in malignant disease. In: McArthur JR, Schechter GP, Schrier SL (eds) Hematology 1998 The American Society of Hematology Education Program Book: Washington 1998 pp 342–370
Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeoablative therapy Blood 1997 89: 4331–4336
Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases Blood 1998 91: 756–763
Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J Clin Oncol 1998 16: 2817–2824
Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B et al. Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy Am J Hematol 1995 48: 100–103
Gómez-Almaguer D, Ruiz-Argüelles GJ, Ruiz-Argüelles A, Piñeiro LA . Dos casos de trasplante heterólogo con sangre periférica Rev Invest Clin Méx 1997 49: 41–45
Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B et al. Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis Am J Hematol 1998 58: 161–164
Kessinger A, Armitage JO, Landmark JD et al. Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy Blood 1998 71: 723–727
Ruiz-Argüelles A . Flow cytometry in the clinical laboratory. Principles, applications and problems Ann Biol Clin 1992 50: 735–743
Ruiz-Argüelles A, Orfao A . Caracterización y evaluación de células totipotenciales en sangre periférica y médula ósea. In: Ruiz-Argüelles GJ, San-Miguel JF (eds) Actualización en Leucemias Editorial Médica Panamericana: México City 1996 pp 79–82
Pinkel D, Straume T, Gray JW . Citogenetic analysis using quantitative, high sensitivity fluorescence hybridization Proc Natl Acad Sci USA 1996 83: 2934–2938
Armitage JO . Bone marrow transplantation New Engl J Med 1994 330: 827–838
Thomas ED . Hematopoietic stem cell transplantation Sci Am 1995 272: 38–47
Ruiz-Argüelles GJ, Bruno GV . Trasplante de células toti-potenciales hematopoyéticas. In: Castellanos-Coutiño J (ed) Temas de Medicina Interna: Transplante de órganos. Asociación de Medicina Interna de México McGraw Hill/Interamericana: México City 1998 pp 85–99
Vesole DH, Tricot G, Jagannath S, et al . Autotransplants in multiple myeloma: what have we learned? Blood 1996 88: 838–847
Ruiz-Argüelles GJ, Apreza-Molina MG, Alemán-Hoey DD et al. Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia (AML) is feasible: a multicentre study Eur J Haematol 1995 54: 18–20
Ruiz-Argüelles GJ, Lobato-Mendizábal E, Delgado-Lamas JL, Gómez-Almaguer D . All trans-retinoic acid decreases early mortality in patients with promyelocytic leukemia and can be given entirely on an outpatient basis Am J Hematol 1999 62: 139–143
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gómez-Almaguer, D., Ruiz-Argüelles, G., Ruiz-Argüelles, A. et al. Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases. Bone Marrow Transplant 25, 131–133 (2000). https://doi.org/10.1038/sj.bmt.1702100
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702100
Keywords
This article is cited by
-
Assessing the efficacy of an ambulatory peripheral blood hematopoietic stem cell transplant program using reduced intensity conditioning in a low-middle-income country
Bone Marrow Transplantation (2019)
-
Latin America: the next region for haematopoietic transplant progress
Bone Marrow Transplantation (2017)
-
Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method
Annals of Hematology (2010)
-
Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?
Bone Marrow Transplantation (2008)
-
Outpatient allografting using non-myeloablative conditioning: the Mexican experience
Bone Marrow Transplantation (2007)